In lung adenocarcinoma, it inhibits tumor growth by targeting the GOLM1/JAK-STAT pathway [35], while in myoblasts, it promotes differentiation by suppressing proliferation [36]. Here, SOAT1 is linked to lung adenocarcinoma.